UroGen Pharma Ownership | Who Owns UroGen Pharma?
UroGen Pharma Ownership Summary
UroGen Pharma is owned by 81.50% institutional investors, 9.18% insiders, and 9.32% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 10.66% of URGN shares. UBS (Lux) Digital Health Equity SB USD is the top mutual fund, with 3.13% of its assets in UroGen Pharma shares.
URGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | UroGen Pharma | 81.50% | 9.18% | 9.32% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 3.56M | 10.66% | $59.69M |
| Adage capital partners gp | 3.30M | 9.89% | $55.37M |
| Great point partners | 2.91M | 8.71% | $48.77M |
| Point72 asset management | 2.45M | 7.34% | $41.10M |
| Menora mivtachim | 2.30M | 6.90% | $38.64M |
| Blackrock | 2.19M | 6.57% | $36.81M |
| Cowen and company | 2.10M | 6.29% | $35.23M |
| Morgan stanley | 1.84M | 5.51% | $30.85M |
| Cormorant asset management, lp | 1.65M | 4.94% | $27.69M |
| Ubs asset management americas | 1.32M | 3.95% | $22.15M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Great point partners | 2.91M | 9.34% | $48.77M |
| Silverarc capital management | 1.10M | 4.36% | $18.49M |
| Wildcat capital management | 495.61K | 2.09% | $5.28M |
| Dafna capital management | 469.00K | 1.88% | $7.87M |
| Cormorant asset management, lp | 1.65M | 1.60% | $27.69M |
| Opaleye management | 412.00K | 1.58% | $6.91M |
| Cowen and company | 2.10M | 0.97% | $35.23M |
| Rtw investments, lp | 3.56M | 0.92% | $59.69M |
| Parkman healthcare partners | 274.46K | 0.62% | $4.61M |
| De lisle partners llp | 81.51K | 0.30% | $1.37M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 3.30M | 0.10% | 2.00M |
| Cormorant asset management, lp | 1.65M | 1.60% | 1.65M |
| Morgan stanley | 1.84M | 0.00% | 1.45M |
| Point72 asset management | 2.45M | 0.11% | 1.34M |
| Ubs asset management americas | 1.32M | 0.01% | 1.32M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.08M |
| Superstring capital management lp | - | - | -288.27K |
| Price t rowe associates inc /md/ | 10.95K | - | -256.19K |
| Laurion capital management lp | - | - | -160.60K |
| Atom investors lp | - | - | -144.78K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cormorant asset management, lp | 1.65M | 1.60% | 1.65M | $27.69M |
| Ubs asset management americas | 1.32M | 0.01% | 1.32M | $22.15M |
| Dafna capital management | 469.00K | 1.88% | 469.00K | $7.87M |
| Woodline partners lp | 303.74K | 0.05% | 303.74K | $5.10M |
| Trexquant investment lp | 80.71K | 0.02% | 80.71K | $1.35M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Toronto dominion bank | -6.00 |
| Systm wealth solutions | -48.00 |
| Srs capital advisors | -56.00 |
| Eversource wealth advisors | -57.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 132 | 9.09% | 35,128,434 | -8.10% | 81 | 0.76% | 75 | -5.06% | 30 | 50.00% |
| Jun 30, 2024 | 120 | 2.56% | 38,225,515 | 40.73% | 114 | 2.03% | 78 | 56.00% | 20 | -45.95% |
| Mar 31, 2024 | 117 | 8.33% | 27,162,135 | 26.89% | 75 | 1.71% | 50 | -24.24% | 37 | 85.00% |
| Dec 31, 2023 | 108 | 1.89% | 21,406,800 | 20.71% | 66 | 1.16% | 66 | 6.45% | 20 | -9.09% |
| Sep 30, 2023 | 106 | 19.10% | 17,734,025 | 34.25% | 75 | 2.35% | 62 | 34.78% | 22 | 10.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| UBS (Lux) Digital Health Equity SB USD | 1.32M | 3.13% | - |
| iShares Russell 2000 ETF | 1.01M | 2.40% | -154.00 |
| Fidelity Small Cap Index | 382.75K | 0.91% | -1.45K |
| iShares Russell 2000 Growth ETF | 262.80K | 0.62% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 262.40K | 0.62% | - |
| iShares Biotechnology ETF | 229.90K | 0.54% | 1.22K |
| MEDICAL BioHealth EUR Acc | 188.91K | 0.45% | -232.79K |
| ARK Israel Innovative Technology ETF | 185.79K | 0.44% | - |
| Vanguard Russell 2000 ETF | 183.16K | 0.43% | 6.31K |
| SPDR® Portfolio Developed Wld ex-US ETF | 146.30K | 0.35% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $8.46K |
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $21.12K |
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $21.12K |
| Jan 31, 2025 | Smith Jason Drew | General Counsel | Sell | $30.82K |
| Jan 31, 2025 | Smith Jason Drew | General Counsel | Sell | $37.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 13 |
| 2023 Q3 | - | 1 |
URGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools